Open Access
Issue |
BIO Web Conf.
Volume 166, 2025
2025 International Conference on Biomedical Engineering and Medical Devices (ICBEMD 2025)
|
|
---|---|---|
Article Number | 02002 | |
Number of page(s) | 4 | |
Section | Medical Information and Technological Innovation Research | |
DOI | https://doi.org/10.1051/bioconf/202516602002 | |
Published online | 10 March 2025 |
- World Health Organization. (2022). Cancer. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/cancer [Google Scholar]
- Yu, D. L., Lou, Z. P., Ma, F. Y., & Najafi, M. (2022). The interactions of paclitaxel with the tumor microenvironment. International Immunopharmacology, 105. https://doi.org/10.1016/j.intimp.2022.108558 [Google Scholar]
- Emens, L. A. (2021). Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer. Journal for Immunotherapy of Cancer, 9(8), e002597. https://doi.org/10.1136/jitc-2021-002597 [CrossRef] [PubMed] [Google Scholar]
- Fasching, P. A. (2023). Inferred immune-cell activity is an independent predictor of HER2-negative breast cancer prognosis and response to paclitaxel-based therapy in the GeparSepto trial. Clinical Cancer Research, 29(13), 2456–2465. https://doi.org/10.1158/1078-0432.CCR-22-4005 [CrossRef] [PubMed] [Google Scholar]
- Kalachand, R., Busschots, S., Doherty, B., Kapros, E., Lawlor, D., Hall, N., & Stordal, B. K. (2022). Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer. Cochrane Database of Systematic Reviews, 2022(7), CD008766. https://doi.org/10.1002/14651858.CD008766.pub4 [Google Scholar]
- Peiqi, M. (2003). Research progress of clinical application of paclitaxel. China Medical Guide, 6(3), 210–211. [Google Scholar]
- Tran, L., Xiao, J.-F., Agarwal, N., Duex, J. E., & Theodorescu, D. (2021). Advances in bladder cancer biology and therapy. Nature Reviews Cancer, 21(2), 104–121. https://doi.org/10.1038/s41568-020-00313-1 [CrossRef] [PubMed] [Google Scholar]
- Qichuan, W., Lixin, W., & Xiao, S. (2007). Observation on the efficacy of paclitaxel in the treatment of advanced gastric cancer. Chinese Journal of Practical Medicine, 34(8), 76–77. [Google Scholar]
- Ikeda, N., Arai, R., Soda, S., Inoue, T., Uchida, N., Nakamura, Y., Masawa, M., Kushima, Y., Okutomi, H., Takemasa, A., Shimizu, Y., & Niho, S. (2022). Carboplatin plus nab‐paclitaxel for recurrent small cell lung cancer: A phase II study. Thoracic Cancer, 13(9), 1342–1348. https://doi.org/10.1111/1759-7714.14359 [CrossRef] [PubMed] [Google Scholar]
- Iowa Health Care. (2016). Types of chemotherapy. University of Iowa Hospitals &Clinics. https://uihc.org/health-topics/types-chemotherapy [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.